- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07120802
- Original Trial
Better4All Personalized Intervention Pilot Study (BETTER4ALL)
The BETTER4U project (Preventing obesity through Biologically and bEhaviorally Tailored inTERventions for you) is funded by the European Union (EU) and involves an international consortium consisting of 28 partners across Europe, Israel, and Australia. The project started in November 2023 and will run until October 2027. The main aim of BETTER4U is to improve weight management through a tailor-made intervention, the "BETTER4ALL personalized intervention", using modern monitoring tools and artificial intelligence (AI), including machine learning (ML) practices.
In the context of the BETTER4U project, the present Pilot Study aims to a) evaluate the usability, feasibility and acceptability of the BETTER4U mobile application ("BETTER4U App") and Intervention Platform that will be used to monitor and collect data from participants in the BETTER4ALL personalized intervention (randomized controlled trial; RCT) and b) collect data to evaluate and improve the BETTER4U causal AI models for the prevention of weight gain, before deploying them at large scale, as well as test and identify the optimal ways of delivering the AI-based interventions to the participants. The study will be conducted in seven sites in Cyprus, France, Greece, Poland, Portugal, Spain, and Sweden.
The BETTER4All Pilot Study will be a longitudinal, correlational, observational study, including a total of n=490 participants, equally distributed among the seven sites (i.e. n=70 per site). Specifically, n=60 (± 3-5) "general population" participants (henceforth: "end-users" of the wearables and the BETTER4U App) and n=10 (± 3-5) healthcare or other types of providers (henceforth: potential "implementers" of the BETTER4U intervention) will constitute each site's sample.
The study will involve the following two components: a) the administration of the wearables (smartwatches) to the "end-users" and their registration to and training on the BETTER4U App, to be used for a total duration of three weeks (21 days). During this period, their lifestyle behaviours (i.e. "BETTER4U Core Behavioural Indicators - BCBIs", such as eating occasions, physical activity, sedentary time, sleep etc.) and "living environment indicators - LEIs"; (e.g. access to parks in your area, distance from your home to your work place etc.) will be recorded daily, either in an automated way via the wearables or self-reported by the end-users through the App; and b) the registration to and training on the BETTER4U Intervention Platform of the "implementers" for a total duration of one week (7 days), during which they will be asked to test the platform's functionalities using synthetic data. The implementers will also be provided with the wearables and the App (similarly to the end-users) for one week only to allow collection of additional data that will help verify the accuracy of the algorithms in the gathered data from the wearables/monitoring tools regarding BCBIs and LEIs.
Overall, the outcomes and the findings of the Pilot Study will be used to further refine, optimize, and adjust the tools for the BETTER4ALL RCT, according to the feedback received by both end-users' and implementers' perspectives.
Study Overview
Status
Conditions
Detailed Description
The BETTER4All Pilot Study is a multicenter, longitudinal, observational study designed to assess the usability, feasibility, and acceptability of the BETTER4U App and BETTER4U Intervention Platform, both of which integrate real-time behavioral monitoring and artificial intelligence (AI)-driven decision support tools. Conducted in seven European countries (Cyprus, France, Greece, Poland, Portugal, Spain, and Sweden), the study includes approximately 490 adult participants split into two groups: (a) "end-users" from the general population, who will use wearable devices and the mobile App for 21 days, and (b) "implementers," healthcare professionals who will test the intervention platform for 7 days using synthetic and self-recorded data.
The BETTER4U system employs Bluetooth Low Energy (BLE) smartwatches for passive data collection, including accelerometer signals, heart rate variability, sleep structure, and geolocation data. Data from the wearables and smartphone sensors are processed using AI and machine learning algorithms to derive behavioral indicators such as physical activity, eating, sleep patterns (termed BETTER4U Core Behavioral Indicators - BCBIs), and contextual environmental factors (Living Environment Indicators - LEIs). These indicators are calculated both locally and on secure servers via structured data pipelines, ensuring privacy and GDPR compliance.
Data collection comprises three sources: (1) passively collected wearable/App data, (2) online questionnaires via RedCap (e.g., IPAQ, GAD-2, PHQ-2, EQ-5D-5L, PSQI, Mini-EAT), and (3) "ground truth" data logged by implementers to validate algorithmic outputs. Engagement metrics, such as app usage duration and feature interaction frequency, are also automatically recorded. Feedback on usability and feasibility is collected via validated tools, including the System Usability Scale (SUS), MAUQ, AIM, IAM, and FIM.
The primary technical aim is to verify and refine the causal AI models developed in earlier project phases (WP5), ensuring the system is optimized for personalized intervention delivery in the upcoming BETTER4ALL randomized controlled trial (WP7).
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Yannis Manios, Professor
- Phone Number: +30 2109549156
- Email: manios@hua.gr
Study Locations
-
-
-
Nicosia, Cyprus, 2109
- Recruiting
- University of Cyprus (Ucy)
-
Contact:
- Constantinos Deltas, Professor
-
-
-
-
-
Villeurbanne, France, 69622 CEDEX
- Recruiting
- Universite Lyon 1 Claude Bernard (Ucbl)
-
Contact:
- Julie-Anne Nazare
-
-
-
-
Aticca
-
Athens, Aticca, Greece, 17676
- Recruiting
- Harokopio University
-
Contact:
- Yannis Manios, Professor
- Phone Number: +30 2109549156
- Email: manios@hua.gr
-
Contact:
- Eva Karaglani
- Phone Number: +30 2109549340
- Email: ekaragl@hua.gr
-
-
-
-
-
Wrocław, Poland, 53-238
- Recruiting
- Uniwersytet Swps (Swps)
-
Contact:
- Aleksandra L, Professor
-
-
-
-
-
Lisboa, Portugal, 1649-016
- Recruiting
- Centro de Estudos E Investigacao Em Dinamicas Sociais E Saude Associacao Sem Fins Lucrativos (Ceidss)
-
Contact:
- Ana Isabel Rito, Professor
-
-
-
-
Navarra
-
Pamplona, Navarra, Spain, 31008
- Recruiting
- Universidad de Navarra (Unav)
-
Contact:
- Mai Bes-Rastrollo, Professor
-
-
-
-
-
Huddinge, Sweden, 141 83
- Recruiting
- Karolinska Institutet
-
Contact:
- Ioannis Ioakeimidis
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age: Participants aged 18-65 years to represent the adult general population.
Body Mass Index (BMI):
- Overweight or obesity group: BMI ≥ 25 kg/m².
- Normal weight group: BMI 18.5-24.9 kg/m².
Technology Use:
- Willingness and ability to use wearable devices and an Android mobile application for the duration of the study.
- Owning a smartphone device with the Android operating system.
- Eating utensil technique: dominant hand gestures that correspond to handling of food via a fork or a spoon.
- Language Proficiency: Ability to read and understand the language in which the mobile app and study materials are provided.
- Consent: Willing to provide informed consent to participate in the study.
- Residency: Must be a resident of one of the seven participating countries.
- Availability: Able to participate for the full three-week duration of the study and comply with the study protocol.
Exclusion Criteria:
- Health Conditions: Pregnant or breastfeeding women, as they might have different lifestyle behaviours or health needs.
- Physical Limitations: Any physical or mental condition that would prevent the participant from using the wearable device or mobile application as intended.
- Eating utensil technique: eating food with chopsticks on a daily or regular basis.
- Technical Incompatibility: Individuals who do not own a compatible smartphone or are unable to use the provided wearable devices for technical reasons.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: End-users - General Population Participants
Adults from the general population (aged 18- 65 years, with normal weight or overweight/obesity) who will use the BETTER4U mobile application and a wearable smartwatch for 21 days.
During this period, lifestyle behaviors and living environment indicators will be recorded daily, either automatically via the wearable or through self-reports via the app.
|
Participants from the general population ("end-users") will use a smartwatch and the BETTER4U mobile app for 21 days.
The app passively collects data (physical activity, sleep, eating behaviors, environment), while participants may self-report certain behaviors.
The goal is to assess the usability, feasibility, and acceptability of the tools and to collect real-world behavioral data for refining AI models.
|
|
Other: Implementers - Healthcare Professionals
Healthcare professionals (e.g., medical doctors, dietitians/nutritionists, psychologists, nurses) who will use the BETTER4U Intervention Platform, mobile application, and wearable smartwatch for 7 days.
During this period, they will interact daily with the Intervention Platform using synthetic data to evaluate its functionalities and usability.
Additionally, they will wear the smartwatch and use the app to record lifestyle behavior and living environment indicators (LEIs).
They will provide structured "growth truth" data (e.g., transportation mode, activity levels, sleep quality) to validate the accuracy of the AI algorithms.
Their feedback will help optimize their intervention delivery system and AI-based tools before large-scale deployment.
|
Healthcare professionals and other potential implementers will test the BETTER4U Intervention Platform and mobile app for 7 days.
They will assess system usability, complete synthetic case simulations, and provide daily feedback via Google Forms.
They also wear the smartwatch and use the app for data validation purposes.
The goal is to evaluate platform usability and collect ground-truth data for validating AI algorithm outputs.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
System Usability Scale (SUS) Score - End-Users
Time Frame: Day 21 (end of participation period for end-users)
|
Usability of the BETTER4U App as reported by end-users using the validated SUS questionnaire (10 items, total score 0-100).
|
Day 21 (end of participation period for end-users)
|
|
System Usability Scale (SUS) Score - Implementers
Time Frame: Day 7 (end of participation period for implementers
|
Usability of the BETTER4U App and Intervention Platform as reported by implementers using the validated SUS questionnaire.
Unit of Measure: Mean SUS score (0-100).
|
Day 7 (end of participation period for implementers
|
|
Acceptability of Intervention Measure (AIM) Score - End-Users
Time Frame: Day 21
|
Acceptability of the BETTER4U App rated by end-users using the AIM (4 items, 5-point Likert scale).
Unit of Measure: Mean AIM score (1-5)
|
Day 21
|
|
AIM Score - Implementers
Time Frame: Day 7
|
Acceptability of the BETTER4U Intervention Platform rated by implementers using AIM.
Mean AIM score (1-5)
|
Day 7
|
|
Feasibility of Intervention Measure (FIM) Score - End-Users
Time Frame: Day 21
|
Feasibility of the BETTER4U App as perceived by end-users.
Mean FIM score (1-5)
|
Day 21
|
|
FIM Score - Implementers
Time Frame: Day 7
|
Feasibility of the BETTER4U Intervention Platform as perceived by implementers.
Mean FIM score (1-5).
|
Day 7
|
|
Intervention Appropriateness Measure (IAM) Score - End-Users
Time Frame: Day 21
|
Appropriateness of the BETTER4U App as rated by end-users.
Mean IAM score (1-5).
|
Day 21
|
|
IAM Score - Implementers
Time Frame: Day 7
|
Appropriateness of the BETTER4U Intervention Platform as rated by implementers.Mean IAM score (1-5)
|
Day 7
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
mHealth App Usability Questionnaire (MAUQ) Score - Implementers
Time Frame: Day 7
|
Usability of the Intervention Platform among implementers, assessed with the adapted MAUQ.
|
Day 7
|
|
App Usage - Number of Logins (End-Users)
Time Frame: Day 21
|
App engagement as measured by the number of logins during the study.
Mean number of logins per participant
|
Day 21
|
|
App Usage - Time Spent per Module (End-Users)
Time Frame: Day 21
|
Engagement measured by the average time (in minutes) spent per module within the BETTER4U App.
Mean time (minutes) per module.
|
Day 21
|
|
Thematic Analysis of Open Feedback (Qualitative)
Time Frame: Day 21 (end-users) / Day 7 (implementers)
|
Qualitative analysis of open-ended feedback provided by participants regarding the usability and content of the BETTER4U tools.
|
Day 21 (end-users) / Day 7 (implementers)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Yannis Manios, Professor, Department of Nutrition and Dietetics, School of Health Science & Education, Harokopio University, Athens, Greece
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- B4U101080117
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity Prevention
-
Augusta UniversityEnrolling by invitationObesity PreventionUnited States
-
Amsterdam University Medical Centers (UMC), Location...CompletedObesity Prevention | Microbiome AnalysisNetherlands
-
Northwell HealthNational Heart, Lung, and Blood Institute (NHLBI)RecruitingPrevention Childhood Obesity | Feasibility and AcceptabilityUnited States
-
Marie HERRCompletedObesity Prevention | Cancer PreventionFrance
-
University of TorontoThe Hospital for Sick Children; Dairy Farmers of CanadaCompletedDiabetes Prevention | Obesity PreventionCanada
-
University of TorontoNatural Sciences and Engineering Research Council, Canada; Mondelēz International... and other collaboratorsCompletedDiabetes Prevention | Obesity PreventionCanada
-
University of TorontoNatural Sciences and Engineering Research Council, Canada; Mondelēz International...CompletedDiabetes Prevention | Obesity PreventionCanada
-
University of TorontoIngredion IncorporatedCompletedDiabetes Prevention | Obesity PreventionCanada
-
University of TorontoIngredion IncorporatedCompletedDiabetes Prevention | Obesity PreventionCanada
-
Centre d'Etudes et de Documentation du SucreMinistry of Higher Education and Research, France; Paris Academy (Rectorat... and other collaboratorsCompletedPrimary Prevention | Obesity Prevention | Body Weight ControlFrance
Clinical Trials on BETTER4U Mobile App and Wearable Use (End-User Group)
-
Indiana UniversityNational Institute of Mental Health (NIMH)Enrolling by invitationBehavioral Health Client-centered SupervisionUnited States
-
Saglik Bilimleri UniversitesiNot yet recruiting
-
Newel Health SRLMichael J. Fox Foundation for Parkinson's Research; Mediolanum Cardio ResearchCompletedParkinson DiseaseItaly
-
University of AlicanteCompletedHypertension | Obesity | Body Weight | Diet, Healthy | Machine Learning | Cholesterol; LipidosisSpain
-
Andreia LoboUniversity of Beira Interior; Centro Hospitalar Universitário de CoimbraCompletedMetabolic Syndrome (MetS)Portugal
-
Marmara UniversityUnknownDiabetes Mellitus, Type 2Turkey
-
Hospital Nacional Profesor Alejandro PosadasInstituto Ecuatoriano de Enfermedades Digestivas; Hospital Nacional Cayetano...RecruitingQuality of Life | Inflammatory Bowel Diseases | Knowledge, Attitudes, Practice | Treatment Adherence and ComplianceArgentina
-
Sanko UniversityUniversity of GaziantepCompletedBreast CancerTurkey (Türkiye)
-
BetterMe LimitedNot yet recruitingObesity & OverweightUnited States
-
Wake Forest University Health SciencesRecruiting